Logo
  Friday, December 4, 2020
Sign-In  |  Sign-Up  |  Contact Us  |  Bookmark 

Moscow's Arbitration Court refused once again Thursday to revoke the license of pharmaceutical company Bryntsalov-A over uncovered violations
Moscow's Arbitration Court refused once again Thursday to revoke the license of pharmaceutical company Bryntsalov-A over uncovered violations, but fined the firm $1,500. Russia's healthcare watchdog had made a second request for the company's license to be suspended after inspections uncovered a series of violations. Bryntsalov-A, which produces cheaper substitutes for popular foreign brands in Russia, has gained a dubious reputation over accusation from some pharmaceutical producers that it sells unlicensed medication. Defense lawyers of the pharmaceutical company said they were unlikely to appeal the ruling, and the Federal Service for the Oversight of Public Health and Social Affairs declined to say whether they would question the court's decision. The chief spokesperson for Bryntsalov-A, Nadezhda Gritsenko, said all the discovered violations related only to the production process, but not to the quality of the company's medicines. In mid-November, the court passed an identical ruling on a suit filed by a healthcare watchdog, demanding license suspension for the firm after inspections uncovered counterfeit medicine at a company's storehouse. Bryntsalov-A is controlled by Russian pharmaceuticals and vodka tycoon Vladimir Bryntsalov, who is also a former presidential candidate. Bryntsalov-A had called on the service to withdraw the suit, saying all uncovered violations had been corrected, and arguing that the suspension of the company's activities would damage the firm and undermine a government program to provide medicine for poor people, toward which the company is contributing $450,000-worth of medication. The Russian healthcare watchdog recently launched a campaign to curb the spread of counterfeit pharmaceutical products in Russia, saying counterfeit medicine accounts for 50% of the market. However, market experts put the figure at only 4%.
Print Moscow's Arbitration Court refused once again Thursday to revoke the license of pharmaceutical company Bryntsalov-A over uncovered violations Bookmark Moscow's Arbitration Court refused once again Thursday to revoke the license of pharmaceutical company Bryntsalov-A over uncovered violations

Related News   
DecJanuary 2007Feb
MoTuWeThFrSaSu
25262728293031
1234567
891011121314
15161718192021
22232425262728
2930311234